Skip to Content
 
Center for International Blood and Marrow Transplant Research

MM25-02

Main Content

Outcomes of Out-of-specification BCMA-directed Chimeric antigen receptor (CAR) T-cell therapies in patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma

Study #: MM25-02

Study Status: Protocol Development